Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 110 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Hydroxymethylglutaryl-CoA Reductase Inhibitors  [Clear All Filters]
2017
Athyros, V. G., Tziomalos K., Doumas M., Sfikas G., & Karagiannis A. (2017).  The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.. Curr Pharm Des. 23(10), 1477-1483.
Polychronopoulos, G., & Tziomalos K. (2017).  Novel treatment options for the management of heterozygous familial hypercholesterolemia.. Expert Rev Clin Pharmacol. 10(12), 1375-1381.
Tziomalos, K., Dimitriou P., Bouziana S. D., Spanou M., Kostaki S., Angelopoulou S-M., et al. (2017).  Stress hyperglycemia and acute ischemic stroke in-hospital outcome.. Metabolism. 67, 99-105.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Proietti, M., Laroche C., Nyvad O., Haberka M., Vassilikos V. P., Maggioni A. P., et al. (2017).  Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.. Int J Cardiol. 248, 166-172.
2016
Athyros, V. Gabriel, Doumas M., & Karagiannis A. (2016).  Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.. Indian Heart J. 68(5), 596-598.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2016).  Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs.. Curr Vasc Pharmacol. 14(2), 208-10.
Katsiki, N., Athyros V. G., & Karagiannis A. (2016).  Exploring the Management of Statin Intolerant Patients: 2016 and Beyond.. Curr Vasc Pharmacol. 14(6), 523-533.
Klontzas, M. E., Kenanidis E. I., MacFarlane R. J., Michail T., Potoupnis M. E., Heliotis M., et al. (2016).  Investigational drugs for fracture healing: preclinical & clinical data.. Expert Opin Investig Drugs. 25(5), 585-96.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
Giannopoulos, A. A., Giannoglou G. D., & Chatzizisis Y. S. (2016).  Pharmacological approaches of refractory angina.. Pharmacol Ther. 163, 118-31.
Lefkou, E., Mamopoulos A., Dagklis T., Vosnakis C., Rousso D., & Girardi G. (2016).  Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.. J Clin Invest. 126(8), 2933-40.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and Type 2 Diabetes Mellitus: An Update After 1 Year.. Curr Pharm Des. 22(18), 2723-5.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.